Home»News, Latest News, Daily News, Recent News, Live News, Current News & Online Updated News of The World by Category - weSRCH
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech:-Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine:-Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech:-Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business:-Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation
Most Popular:-Last 24 Hours, Last 7 Days, Last 30 Days, ALL

Twitter Trends


Latest News, Top News, Breaking News

Narrow Search   Exclude Keywords  
Total record(s) 1145 , Page No. 1 , Max 20 Records Per Page -
Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
Could African Crops Be Improved With Private Biotech Data? - NPR (blog)
  NPR (blog) "I'm shocked by the optimism here," Howard Yana-Shapiro, the chief agricultural officer for Mars Inc. said Tuesday to the audience of the Chicago Council on Global Affairs' Global Food Security Symposium ....more | Save |   Email 22nd May 2013 
 
NPS Pharmaceuticals to Present at Deutsche Bank Health Care Conference - Financial Post
  NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Deutsche Bank Securities 38th Annual Health Care Conference in Boston on Wednesday, May 29, 2013 at 8:00 a.m. ET. The presentation will be available as a ....more | Save |   Email 22nd May 2013 
 
NPS Pharmaceuticals to Present at Deutsche Bank Health Care Conference - National Post
  NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Deutsche Bank Securities 38th Annual Health Care Conference in Boston on Wednesday, May 29, 2013 at 8:00 a.m. ET. The presentation will be available as a l ....more | Save |   Email 22nd May 2013 
 
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG ... - PR Newswire (press release)
  NEW YORK, May 22, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of AMAG Pharmaceutic ....more | Save |   Email 22nd May 2013 
 
ONCOGENEX PHARMACEUTICALS INC : OncoGenex Announces Multiple ... - 4-traders (press release)
  BOTHELL, Wash. and VANCOUVER, British Columbia, May 22, 2013 /CNW/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), a leader in the development of novel therapeutics to target mechanisms of treatment resistanc ....more | Save |   Email 22nd May 2013 
 
People in the News: Charles Lee - GenomeWeb
  Log in or Register. Wednesday, May 22, 2013. Arrays · Clinical Genomics · Informatics · PCR/Sample Prep · Proteomics · RNAi · Sequencing · Videos · Home » News » Pharmacogenomics Reporter ...and more&n ....more | Save |   Email 22nd May 2013 
 
Supreme Court rules in favor of Monsanto in biotech seed patent case - Agri-View
  Western Farm Press This closely watched case pitted agricultural biotech giant Monsanto against an Indiana farmer who planted a second generation of the company's patented soybean seeds. The Supreme Court found for Mons ....more | Save |   Email 22nd May 2013 
 
Who Controls Your Genetic Information? Genomics Ethics Tackled In New ... - BioNews Texas
  BioNews Texas ... sequencing in multiple medical situations, including the molecular characterization of rare diseases, the individualization of treatment (particularly in cancer), pharmacogenomics, preconception/p ....more | Save |   Email 22nd May 2013 
 
Biotech ETF Rallies Over 30% as Cash Tumbles In - ETF Trends
  The iShares Biotech ETF (NasdaqGM: IBB) is up more than 30% so far in 2013 and other exchange traded funds tracking the sector are raking in money are investors chase the hot performance. Other funds in the category include SPDR S&P Biote ....more | Save |   Email 22nd May 2013 
 
Novo A/S acquires Xellia Pharmaceuticals for $ 700 million - PharmaLive (press release) (subscription)
  Oslo, Norway and Copenhagen, Denmark, May 21 2013 - Xellia Pharmaceuticals ("Xellia?), a pharmaceutical group focusing on the development, manufacturing and global commercialization of anti-infectiv ....more | Save |   Email 22nd May 2013 
 
Biotech Investing for Beginners - Motley Fool
  Huge fortunes are won and lost in the world of biotech nearly every week. For those new to this world, it can appear both alluring and scary. Biotech investing for beginners isn't for the fainthearted, but the potential rewards are great. Here are ...an ....more | Save |   Email 22nd May 2013 
 
Tweets of the day, 5/22/2013 - PharmaLive (press release) (subscription)
  Today is one of those time-compressed days where I have to get other stuff (like this roundup) completed between three interviews for another story. I've been following some of the FDA advisory board meeting where M ....more | Save |   Email 22nd May 2013 
 
Swiss Billionaires Buy Merck Geneva Building for Biotech Campus - Bloomberg
  Yahoo! News "This project constitutes a unique opportunity to increase research and development in the biotechnology sector of the Lake Geneva region and its related job creation,? Patrick Aebischer, president of the Lausanne- ....more | Save |   Email 22nd May 2013 
 
Biotech labeling drive not going away, Merrigan says - Agri-Pulse
  Merrigan pointed out that neither USDA nor the Food and Drug administration has allowed an organic producer to use a biotech-free label, although USDA's National Organic Program bars biotechnology from production of organic food. &qu ....more | Save |   Email 22nd May 2013 
 
Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc ... - PR Newswire (press release)
  RALEIGH, N.C., May 22, 2013 /PRNewswire/ -- STEPh, Inc., a full service medical communications company, is pleased to announce the launch of their web site ( http://www.stephreports.com ) dedicate ....more | Save |   Email 22nd May 2013 
 
Portola Pharmaceuticals prices upsized IPO at $14.50, within the range - NASDAQ
  Portola Pharmaceuticals, which is developing a blood thinner and a novel reversal agent for acutely ill patients, raised $122 million in an upsized IPO by offering 8.4 million shares at $14.50, the midpoint of the $13 to $1 ....more | Save |   Email 22nd May 2013 
 
IPOVIEW-Quiet US biotech sector picks up steam in 2013 - Reuters
  May 22 (Reuters) - The tide may have started to turn for initial public offerings from U.S. biotechnology companies, as a rising stock market, low interest rates and a lack of market volatility entice investors to take on the high risk in ....more | Save |   Email 22nd May 2013 
 
Swiss billionaires buy Merck Serono HQ for biotech campus - Reuters
  ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German dr ....more | Save |   Email 22nd May 2013 
 
Debunking Myths About Biotech Venture Capital - Forbes
  There are lots of myths about venture capital and biotech in particular, as noted previously on this blog. Many of these myths are deeply held beliefs about returns, what works and what doesn't, and the state of the industry. Told of ....more | Save |   Email 22nd May 2013 
 
Cancer Diagnostic Testing World Markets - MarketWatch (press release)
  ... Cell Markers 1854.3.8 mAbs 1864.3.9 Proteomics and Cancer Antibodies 1874.3.10 Pharmacogenomics and Oncology Diagnostics 1874.3.11 DNA Microarrays 1904.3.12 In Vitro Diagnostic Multi-variate Index Assays (IVDMIA) 1924.3.13 Prosta ....more | Save |   Email 22nd May 2013 
 
Total record(s) 1145 , Page No. 1 , Max 20 Records Per Page -
Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>

Twitter Trends

 
Close

Please log-in to continue without interruption

Keep me Signed In

Forgot password?

Not a Member?

Register Now to return to the page you were viewing and continue using weSRCH.com without interruption.

- IT'S FREE!

Why be a Member?
  • Create a custom profile for e-mail updates on new papers and newsfeed

    a) Select just the topics you're interested and the update frequency

  • Save newsfeed links from weSRCH.com\mobile for later review

    a) Let's face it, 3G sucks ... bandwidth-wise ...

    i) Who wants to wait for full internet pages when they're mobile.

    b) This feature shows all the headlines in your field with minimal wait.

    c) Save any link to your personal library for later review when you have a high bandwidth connection. We call it myLibrary.

    d) You can even put e-mail alerts for your own keywords.

  • Easy forwarding of papers to your colleagues.

    a) Use myContacts to create connections with other weSRCH members.

    b) Use myAddressbook to store colleague's e-mail addresses for quick forwarding.

  • Post your own papers and news releases for free.

    a) Use myLibrary to manage them.